MNOV
MediciNova, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.63
+0.62%Margins
Gross margin
42.4%
EBITDA margin
-1192.5%
EBIT margin
-1287.4%
Net margin
-1168.2%
FCF margin
—
-28.9%
Return on equity
-26.6%
Return on assets
-31.7%
Return on invested capital
0.02x
Asset turnover
-$1.9B
Cash from operations
$0.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026